Red Light Hollan - TRUFF STOCK NEWS

Red Light Holland Corp. announces strong financial performance with a cash balance of $15.4 million, revenue increase of 9.9% to $1.3 million, and total assets of $27.3 million. The company's strategic growth goals are being met, with sales increasing by 9.9% for the 3-month period and 28.9% for the 9-month period compared to the prior year. Red Light Holland focuses on production, distribution, and marketing to enhance long-term growth and shareholder value.

Red Light Holland to export its largest batch of 5 kg of Psilocybin Truffles to Canada under a 5th Health Canada approved import permit, collaborating with CCrest Laboratories and PharmAla Biotech for R&D towards producing standardized psilocybin products for clinical trials and emerging markets.

Red Light Holland Corp. (TRIP) announces the release of its Q3 2024 financial and operational results on February 29, 2024. CEO Todd Shapiro and CFO David Ascott will conduct a live Q&A session. The company specializes in functional mushrooms and psilocybin truffles in North America, Europe, and the Netherlands.

Red Light Holland partners with PharmAla for GMP Drug Product and Regulatory Development, aiming to expand sales of Psilocybin products to Clinical Trials and emerging markets.

Red Light Holland Corp. announces the launch of its Fresh Mushroom Sales Division, SR Wholesale North America, in partnership with Holburne and F&R Mushroom farms. The company aims to expand its product offerings and market presence by focusing on the sale of high-quality fresh mushrooms, aligning with its mission to contribute to the growth of the exotic fresh mushroom and emerging psychedelics markets. The launch of SR Wholesale North America is expected to meet the increasing demand for natural, health-conscious products and position Red Light Holland as a key player in the evolving industry.

Red Light Holland's psilocybin microdosing capsules, developed from truffles grown in the Netherlands, have received final Product Specification document signed by CCrest Laboratories. The capsules are free of pesticides, bio contaminants, and heavy metals. The company plans to import psilocybin truffles into Canada and connect with NUBU's network of medical doctors in Australia and New Zealand.

Red Light Holland Corp. (CSE: TRIP) announces a new multi-million dollar production facility to increase AEM Farm's mushroom production output by approximately 15-18 million dollars of domestic and international annual sales. The 80,000 square foot state-of-the-art vertical exotic mushroom farm and composting facility is expected to produce over 15,000 tons of mushroom compost annually, leading to more than 7,500,000 pounds of fresh mushrooms per year. The facility will support the Company's global and local operations with high-quality, large-scale exotic mushroom production capabilities. CEO Todd Shapiro emphasizes the company's commitment to growing the psychedelic side of their business. Red Light Holland also plans to share details and updates regarding its partnership with CCrest Labs and NUBU Pharmaceuticals, increasing production and output in the Company's Magic Truffle Farm in Horst, the Netherlands, and its Mushroom Home Grow Kit division. The company has total assets of $28.2 million, including $16.4 million of cash and cash equivalents.

Red Light Holland (TRIP) confirms stability of psilocybin in natural microdosing capsules after five months of tests, following the completion of Certificate Of Analysis. The company plans to import more truffles into Canada and collaborate with Nubu's network of medical doctors.

Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) announced financial highlights for the three and six months ended September 30, 2023, including a cash balance of $16.4 million, revenue of $1.0 million (a 33.5% increase from 2022), gross profit of $0.4 million (a 20.0% increase from 2022), property, plant and equipment value of $5.1 million, and total assets of $28.2 million.